ClinConnect ClinConnect Logo
Search / Trial NCT06734767

The Effect of an MBSR Course on Medical Trainee and Medical Academic Faculty Stress and Burnout

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Dec 13, 2024

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

Burnout Mbsr Mindfulness Physician Well Being

ClinConnect Summary

The study is a pre- and post- survey design with the 8-week MBSR course as the intervention. MBSR is an evidence-based curriculum with a greater than 40-year history, that has been taught at Mount Sinai since 2018. Study participants will be those who have voluntarily signed up to take the course in response to an email describing the course that was sent by the office of the Mount Sinai Graduate Medical Education (GME). The study participants will be separated into two groups: faculty and trainees, and the study will span approximately two weeks prior to the start of the course (9/13/2023)...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - A physician in The Mount Sinai Hospital System
  • Exclusion Criteria:
  • - none

About Icahn School Of Medicine At Mount Sinai

The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Jeffrey Zahn, MD

Principal Investigator

Icahn School of Medicine at Mount Sinai

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported